Germany's New Health Bill Sparks Controversy Among Drugmakers
Published on: July 10, 2026, 6:01 p.m. | Source: Devdiscourse
Germany's parliament passed a bill aimed at controlling health insurance costs, drawing criticism from drugmakers concerned about its impact on profits and innovation. The bill seeks to narrow the health system's funding gap through increased rebates and tighter cost controls, raising concerns about Germany's pharmaceutical industry's competitiveness.
